Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Quasi-partial order continual reassessment method: Applying toxicity scores to cancer dose-finding drug combination trials

(2022)10.1016/j.cct.2022.107050Source: DataRank Database

Quasi-partial order continual reassessment method: Applying toxicity scores to cancer dose-finding drug combination trials is a research paper (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Topics (13)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Nolan A. Wages ORCID,Elizabeth Garrett‐Mayer ORCID,Nathaniel S. O’Connell ORCID

Live enrichment

PubMed:36529437

National Cancer Institute

Grant: F31-CA210380

National Cancer Institute

Grant: R01CA247932

NCI NIH HHS

Grant: F31 CA210380

National Institutes of Health

MeSH Terms

HumansNeoplasmsDrug CombinationsMaximum Tolerated DoseDose-Response Relationship, DrugResearch DesignComputer Simulation

Keywords

Continual Reassessment MethodPhase I TrialCancer TrialDose-finding TrialPartial-order Continual Reassessment MethodQuasi-continual Reassessment Method